2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first synthesized in 1986; its desired effects include both a sense of empathy and of well-being. Hallucinations, nausea, anxiety, panic attacks and paranoid ideation are anecdotally reported. According to the different European sources here approached, the availability of 2C-T-7 at street level seems to be currently very low, although one death related to a mono-i...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
BACKGROUND: The continual diversification of new psychoactive substances (NPS) circumventing legisla...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 ('Blue Mystic'), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
BACKGROUND: The continual diversification of new psychoactive substances (NPS) circumventing legisla...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 ('Blue Mystic'), an illicit compound which shows similarities with MDMA and other designer dr...
2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer dr...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
BACKGROUND: The continual diversification of new psychoactive substances (NPS) circumventing legisla...